Rationale and design of a placebo controlled randomized trial to assess short term, high-dose oral cholecalciferol on select laboratory and genomic responses in African Americans with hypovitaminosis D-Reference-Cited by-同舟云学术

Rationale and design of a placebo controlled randomized trial to assess short term, high-dose oral cholecalciferol on select laboratory and genomic responses in African Americans with hypovitaminosis D

Published:2018-09 Issue: Volume:72 Page:20-25
ISSN:1551-7144
Container-title:Contemporary Clinical Trials
language:en
Short-container-title:Contemporary Clinical Trials

Author:

Norris Keith C.,Edwina Barnett M.,Meng Yuan-Xiang,Martins David,Nicholas Susanne B.,Gibbons Gary H.,Lee Jae Eun

Funder

NIH

Publisher

Elsevier BV

Subject

Pharmacology (medical),General Medicine

Reference57 articles.

1. Heart disease and stroke statistics-2015 update: a report from the American Heart Association;Mozaffarian;Circulation,2015

2. Vitamin D: the more we know, the less we know;Scott;Clin. Chem.,2015

3. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey;Martins;Arch. Intern. Med.,2007

4. Impact of activated vitamin D and race on survival among hemodialysis patients;Wolf;J. Am. Soc. Nephrol.,2008

5. Vitamin D and the cardiovascular system;Artaza;Clin. J. Am. Soc. Nephrol.,2009

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vitamin D3 Repletion Improves Vascular Function, as Measured by Cardiorenal Biomarkers in a High-Risk African American Cohort;Nutrients;2022-08-14

2. Effect of Vitamin D Supplementation in patients with Cardiometabolic disorders- A Clinical Study in Ahmedabad population;Research Journal of Pharmacy and Technology;2022-04-23

3. Differences in RAAS/vitamin D linked to genetics and socioeconomic factors could explain the higher mortality rate in African Americans with COVID-19;Therapeutic Advances in Cardiovascular Disease;2020-01

4. The Research Centers in Minority Institutions (RCMI) Translational Research Network: Building and Sustaining Capacity for Multi-Site Basic Biomedical, Clinical and Behavioral Research;Ethnicity & Disease;2019-02-21